1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Medical Marijuana Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Medical Marijuana Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1
- 5.1.2 Growing acceptance and legalization of medical marijuana for various health conditions and treatments.
- 5.1.3 Increasing awareness among patients and healthcare providers about the therapeutic benefits of cannabis.
- 5.1.4 Rising prevalence of chronic diseases and mental health disorders driving demand for alternative therapies.
5.2 Market Opportunities
- 5.2.1
- 5.2.2 Development of new medical marijuana formulations and delivery methods tailored to specific patient needs.
- 5.2.3 Expansion into international markets where medical cannabis regulations are evolving and becoming more favorable.
- 5.2.4 Opportunities for research and clinical trials to explore additional therapeutic applications of medical marijuana.
5.3 Future Trends
- 5.3.1
- 5.3.2 Increasing focus on personalized medicine and targeted therapies using cannabinoid profiles for specific health conditions.
- 5.3.3 Advancements in cultivation and extraction technologies improving product quality and consistency.
- 5.3.4 Growing emphasis on education and training for healthcare professionals to ensure informed prescribing and patient care.
5.4 Impact of Drivers and Restraints
6. North America Medical Marijuana Market Regional Analysis
6.1 North America Medical Marijuana Market Overview
6.2 North America Medical Marijuana Market Revenue 2020-2028 (US$ Million)
6.3 North America Medical Marijuana Market Forecast Analysis
7. North America Medical Marijuana Market Analysis – by Product Type
7.1 Dried Form
- 7.1.1 Overview
- 7.1.2 Dried Form: North America Medical Marijuana Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Extract Form
- 7.2.1 Overview
- 7.2.2 Extract Form: North America Medical Marijuana Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Medical Marijuana Market Analysis – by Application
8.1 Pain Management
- 8.1.1 Overview
- 8.1.2 Pain Management: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Tourette's
- 8.2.1 Overview
- 8.2.2 Tourette's: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Alzheimer's Disease
- 8.3.1 Overview
- 8.3.2 Alzheimer's Disease: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Migraines
- 8.4.1 Overview
- 8.4.2 Migraines: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Depression and Anxiety
- 8.5.1 Overview
- 8.5.2 Depression and Anxiety: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Multiple Sclerosis
- 8.6.1 Overview
- 8.6.2 Multiple Sclerosis: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Cancer
- 8.7.1 Overview
- 8.7.2 Cancer: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Medical Marijuana Market Analysis – by Distribution Channel
9.1 Retail Pharmacy
- 9.1.1 Overview
- 9.1.2 Cancer: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
9.2 E-Commerce
- 9.2.1 Overview
- 9.2.2 Cancer: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Medical Marijuana Market – North America Analysis
10.1 North America
- 10.1.1 North America Medical Marijuana Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.1.1.1 North America Medical Marijuana Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 US: North America Medical Marijuana Market Breakdown, by Product Type
- 10.1.1.1.2 US: North America Medical Marijuana Market Breakdown, by Application
- 10.1.1.1.3 US: North America Medical Marijuana Market Breakdown, by Distribution Channel
- 10.1.1.2 Canada:
North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Canada: North America Medical Marijuana Market Breakdown, by Product Type
- 10.1.1.2.2 Canada: North America Medical Marijuana Market Breakdown, by Application
- 10.1.1.2.3 Canada: North America Medical Marijuana Market Breakdown, by Distribution Channel
- 10.1.1.3 Mexico :
North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Mexico : North America Medical Marijuana Market Breakdown, by Product Type
- 10.1.1.3.2 Mexico : North America Medical Marijuana Market Breakdown, by Application
- 10.1.1.3.3 Mexico : North America Medical Marijuana Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Medical Marijuana Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Aphria, Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 CanaQuest Medical Corporation
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Canopy Growth Corporation
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Emerald Health Therapeutics Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 GW Pharmaceuticals
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 MARICANN INC.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Organigram Holdings Inc.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Panaxia Pharmaceutical Industries Ltd.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Phoena Holdings Inc.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 VIVO Cannabis Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For North America Medical Marijuana Market
